Clinical trialNCT03578783CompletedPhase 2Interventional

PSD502 in Subjects With Premature Ejaculation

SponsorPlethora Solutions LtdEnrollment121Premature Ejaculation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of the subjects will receive PSD502 and half will receive placebo.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jed Kaminetsky, MD, BA
Manhattan Medical Research, 215 Lexington Avenue, 21st Floor, New York, NY 10016
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Achieve Clinical Research
Birmingham, Alabama, United States
Coastal Clinical Research
Mobile, Alabama, United States
Skyline Urology
Sherman Oaks, California, United States
Imagine Research of Palm Beach County
Boynton Beach, Florida, United States
Suncoast Research
Miami, Florida, United States
Suncoast Research Associates
Miami Lakes, Florida, United States
Clinical Research Center of Florida
Pompano Beach, Florida, United States
Primary Care Research
Atlanta, Georgia, United States
Georgia Clinical Research, Llc
Lawrenceville, Georgia, United States
Regional Urology, Llc
Shreveport, Louisiana, United States
Chesapeake Urology Research Associates
Towson, Maryland, United States
Boston Clinical Trials
Boston, Massachusetts, United States
Mens Health Boston
Chestnut Hill, Massachusetts, United States
Jubilee Clinical Research, Inc
Las Vegas, Nevada, United States
Accumed Research Associates
Garden City, New York, United States
Manhattan Medical Research Practice
New York, New York, United States
Premier Medical Group of the Hudson Valley
Poughkeepsie, New York, United States
M3 Wake Research, Inc
Raleigh, North Carolina, United States
Midlantic Urology
Bala-Cynwyd, Pennsylvania, United States
Advanced Clinical Research - Jordan Ridge Family Medicine
Salt Lake City, Utah, United States
Advanced Clinical Research
West Jordan, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PSD502Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 Dec 2018
Primary completion: 4 May 2021
Completion: 1 Dec 2021
Last update posted: 5 Jul 2022
Registered enrollment: 121
Registry id: NCT03578783

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.